SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-216469
Filing Date
2021-07-15
Accepted
2021-07-15 16:46:59
Documents
15
Period of Report
2021-07-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d125524d8k.htm   iXBRL 8-K 33348
2 EX-10.1 d125524dex101.htm EX-10.1 31874
3 EX-10.2 d125524dex102.htm EX-10.2 8934
7 GRAPHIC g125524nb6.jpg GRAPHIC 17984
  Complete submission text file 0001193125-21-216469.txt   237481

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cbio-20210714.xsd EX-101.SCH 2924
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20210714_lab.xml EX-101.LAB 18138
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20210714_pre.xml EX-101.PRE 11429
8 EXTRACTED XBRL INSTANCE DOCUMENT d125524d8k_htm.xml XML 3341
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 211093126
SIC: 2834 Pharmaceutical Preparations